GILD
GILEAD SCIENCES, INC. · Healthcare · Market cap $190.4B
Insiders sold $15.9M net in the last 90 days ·5 sellers, 0 buyers· 11 of 11 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 16, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$87.9M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 16, 2026
Dickinson Andrew D
GILEAD SCIENCES, INC. (GILD) has 80 SEC Form 4 filings (163 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 16, 2026.
Inside the rolling window, 7 insiders at GILEAD SCIENCES, INC. reported no open-market purchases and 45 open-market sales totaling $87.9M. The most active filer is Chairman & CEO O'Day Daniel Patrick with 14 filings. Insiders have net sold $26.6M over the trailing 6 months. The most recent open-market filing is a sale of 3,000 shares by Chief Financial Officer Dickinson Andrew D, dated Oct 15, 2026, worth $469K.
- Industry:Drug Manufacturers - General
- CEO:Daniel O'Day
- Employees:17,000
- HQ:Foster City, CA, US
- IPO:1992-01-22
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 3,000 | $469K | Oct 16 | -1.7% | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $469K | Oct 16 | -1.7% | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $2.2M | Oct 2 | +6.1% | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $433K | Sep 16 | +4.0% | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $436K | Sep 16 | +4.0% | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $2.2M | Sep 2 | +2.6% | SEC ↗ | |
WELTERS ANTHONYFirst filing | Director | Sale | 18,000 | $2.7M | Aug 27 | — | SEC ↗ |
Bluestone JeffreyFirst in 7 months | Director | Sale | 5,000 | $725K | Aug 21 | — | SEC ↗ |
| Chief Comm & Corp Aff Officer | Sale | 28,000 | $3.9M | Aug 18 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $415K | Aug 18 | — | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $2.0M | Aug 4 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $390K | Jul 16 | — | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $390K | Jul 16 | — | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $1.9M | Jul 2 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $376K | Jun 16 | — | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $372K | Jun 16 | — | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $2.0M | Jun 2 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $397K | May 18 | — | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 28,000 | $3.7M | May 18 | — | SEC ↗ | |
| Chairman & CEO | Sale | 10,000 | $1.3M | Apr 29 | — | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $423K | Apr 16 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $423K | Apr 16 | — | SEC ↗ | |
| Chairman & CEO | Sale | 10,000 | $1.4M | Mar 30 | — | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $433K | Mar 17 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $433K | Mar 17 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading GILD 109 all-time
- DRep. Ro KhannaSale$1,001 - $15,0002026-08-10
- DRep. Ro KhannaSale$1,001 - $15,0002026-07-07
- RSen. Tommy TubervillePurchase$1,001 - $15,0002024-05-10
- RSen. Thomas Hawley TubervillePurchase$1,001 - $15,0002024-05-10
- RSen. Thomas Hawley TubervillePurchase$1,001 - $15,0002024-05-10
- RSen. Thomas Hawley TubervillePurchase$1,001 - $15,0002024-05-10
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does GILD have?
GILEAD SCIENCES, INC. (GILD) has 80 SEC Form 4 filings (163 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 16, 2026.
When was the most recent SEC Form 4 filing for GILD?
The most recent Form 4 filing for GILD on Tracefour is dated Oct 16, 2026.
Who is the most active insider at GILD?
The most active SEC Form 4 filer at GILD in the rolling window is Chairman & CEO O'Day Daniel Patrick, with 14 filings.
What is the net insider flow at GILD over the last 6 months?
Over the trailing 180 days, insiders at GILD have net sold $26.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at GILD in the current window?
Inside the rolling window, insiders at GILD bought $0 and sold $87.9M based on SEC Form 4 filings.
Can I get alerts for GILD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at GILEAD SCIENCES, INC. (GILD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
GILEAD SCIENCES, INC. is in the Healthcare sector.